At the San Antonio Breast Cancer Symposium, Dr. S. P. Somashekhar, chairman of the Manipal Comprehensive Cancer Center in Bengaluru, India, ...
News
- Study: IBM Watson agrees with cancer docs on treatment options 90% of the time
- Puma Biotechnology, Inc. (NYSE:PBYI) announced interim results from a Phase II clinical trial
Puma Biotechnology, Inc. (NYSE:PBYI) traded 1.42 Million shares and was closed at $36.45 per share. The current share price indicates that stock is ...
- Puma Biotechnology Inc.: Puma Biotechnology Presents Interim Results of Phase II CONTROL ...
... (neratinib) were presented at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, ...
- A look at how Texas is advancing in medicine and biotechnology
The Texas business journals in Dallas, San Antonio, Houston and Austin are proud to bring you our inaugural edition of Innovations in Health Care, ...
- Calithera Biosciences announces conference call to be held on December 12
During the call, company will discuss recent CB-839 clinical data presentations made at the San Antonio Breast Cancer Symposium and the ...